29 Décembre 2015
Chimerix Antiviral Candidate Brincidofovir Fails Phase III Trial | GEN News Highlights | GEN
Chimerix said today that its antiviral candidate, brincidofovir, for patients undergoing hematopoietic cell transplantation (HCT) failed its first Phase III trial, with deaths and cytomegalovirus ...